Amanote Research
Register
Sign In
In Vitro Screening for Genetic Signatures Associated With Sensitivity to Targeted Cancer Therapeutics
Science-Business eXchange
doi 10.1038/scibx.2013.1330
Full Text
Open PDF
Abstract
Available in
full text
Date
December 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Cancer Targeted Therapeutics: From Molecules to Drug Delivery Vehicles
Journal of Controlled Release
Pharmaceutical Science
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Bone Marrow Endothelium-Targeted Therapeutics for Metastatic Breast Cancer
Journal of Controlled Release
Pharmaceutical Science
Drug Screening to Target Nuclear Orphan Receptor NR4A2 for Cancer Therapeutics
Translational Lung Cancer Research
Oncology
Targeted Therapeutics
Cell
Biochemistry
Genetics
Molecular Biology
CRADA Final Report: ErbB2 Targeted Cancer Therapeutics
Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
International Journal of Medical Sciences
Medicine
Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics
Pediatric Clinics of North America
Child Health
Pediatrics
Perinatology
Novel Targeted Therapeutics for MEN2
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes